U.S. Markets closed

Principia Biopharma Inc. (PRNB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
100.050.00 (0.00%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close100.05
Open99.99
Bid100.00 x 1200
Ask100.03 x 1100
Day's Range99.95 - 100.15
52 Week Range28.86 - 101.89
Volume1,734,585
Avg. Volume1,732,650
Market Cap3.325B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateNov 03, 2020 - Nov 09, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est86.00
  • Hedge Funds Keep Buying Principia Biopharma Inc. (PRNB)
    Insider Monkey

    Hedge Funds Keep Buying Principia Biopharma Inc. (PRNB)

    We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional investors have to conduct complex analyses, spend many resources and use tools that are not […]

  • SHAREHOLDER ALERT: Monteverde & Associates Is Investigating the Following Merger
    ACCESSWIRE

    SHAREHOLDER ALERT: Monteverde & Associates Is Investigating the Following Merger

    NEW YORK, NY / ACCESSWIRE / September 25, 2020 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating: * Principia Biopharma Inc.

  • READ NOW: Monteverde & Associates PC Investigates the Merger
    ACCESSWIRE

    READ NOW: Monteverde & Associates PC Investigates the Merger

    NEW YORK, NY / ACCESSWIRE / September 19, 2020 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating: * Maxim Integrated Products, Inc.